Viewing StudyNCT00084565



Ignite Creation Date: 2024-05-05 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00084565
Status: WITHDRAWN
Last Update Posted: 2013-07-10
First Post: 2004-06-10

Brief Title: Paclitaxel Topotecan and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer
Sponsor: Fox Chase Cancer Center
Organization: Fox Chase Cancer Center

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Keywords:
Name View
adenocarcinoma of the prostate View
stage IV prostate cancer View